2024-04-25-深交所-贝泰妮_云南贝泰妮生物科技集团股份有限公司2023年年度报告_英文版_242页_2mb

Yunnan Botanee Bio-Technology Group Co., Ltd. 2023 Annual Report Summary

Core Content Overview

This document is the 2023 Annual Report of Yunnan Botanee Bio-Technology Group Co., Ltd. (Botanee), published in April 2024. The report outlines the company's financial performance, corporate governance, operations, and strategic direction for the year ended December 31, 2023.

Main Company Information

• Company Name: Yunnan Botanee Bio-Technology Group Co., Ltd.
• Stock Name: Botanee
• Stock Code: 300957
• Legal Representative: Mr. Guo Zhenyu
• Registered Address: No. 53, Keyi Road, Kunming High-tech Industrial Development Zone, Yunnan Province
• Postal Code: 650106
• Website: http://www.botanee.com.cn/
• Email: ir@botanee.com
• Board Secretary: Mr. Wang Long
• Securities Representative: Ms. Xu Ling
• Phone: 0871-6801 3210
• Fax: 0871-6801 3210

Key Financial Indicators (2023 vs. 2022 vs. 2021)

Non-Recurring Gains and Losses (2023)

• Total Non-Recurring Gains and Losses (after tax): CNY138,736,216.03
• Breakdown:
  • Gains and losses from disposal of non-current assets: CNY461,616.01
  • Government subsidies (non-recurring): CNY131,682,124.63
  • Fair value changes (non-recurring): CNY-17,238,886.41
  • Investment gains (non-recurring): CNY54,656,428.89
  • Other non-operating items: CNY-7,167,283.17
  • Income tax: CNY-22,633,297.72
  • Minority shareholders' interests: CNY1,024,486.20

Dividend Policy

• Cash Dividend per 10 Shares: CNY6.00
• Total Shares: 420,605,382
• Bonus Shares: 0
• Share Repurchase: 0 shares issued for every 10 shares
• Total Dividend Distribution: CNY25,236,322,920.00

Corporate Governance and Supervision

• Accounting Firm: Talent Certified Public Accountants (Special General Partnership)
• Signing Accountants: Wu Ting, Zhang Xuewen
• Continuous Supervision Sponsor: Guosen Securities Co., Ltd.
• Supervision Period: From March 25, 2021 to December 31, 2024
• Representatives: Lou Yu, Wang Donghui

Industry and Business Overview

• Industry Classification:
  • "Manufacture of Chemical Raw Materials and Chemical Products" (C26)
  • "Cosmetics Manufacturing" (C2682)
• Reported Industry: Daily chemical product manufacturing
• Regulatory Requirements:
  • Compliance with Shenzhen Stock Exchange Self-regulatory Guidelines for Listed Companies (No. 3 and No. 4)
• Industry Trends:
  • China's total retail sales of consumer goods grew by 7.24% in 2023
  • Cosmetics and personal care products sales increased by 5.10%
  • The Chinese cosmetics market is expected to continue growing, with a compound annual growth rate of 5.30% from 2018 to 2023

Key Sections of the Report

• Section I: Important notices, table of contents, and definitions
• Section II: Company profile, contact information, and financial indicators
• Section III: Management discussion and analysis
• Section IV: Corporate governance
• Section V: Environmental and social responsibility
• Section VI: Significant events
• Section VII: Shareholding changes
• Section VIII: Preference shares
• Section IX: Bonds
• Section X: Financial report

Documents Available for Inspection

• Original annual report signed by Mr. Guo Zhenyu
• Financial statements signed by Mr. Guo Zhenyu, Mr. Wang Long, and Mr. Liu Zhaofeng
• Audit report signed by Talent Certified Public Accountants
• All public documents and announcements from the reporting period
• These documents are available at the Board Secretary’s Office

Accounting Policies and Standards

• Changes in Accounting Policies: Adjusted according to Interpretation No. 16 of the Ministry of Finance
• Accounting Standards:
  • China Accounting Standards (CAS)
  • International Financial Reporting Standards (IFRS)
  • Overseas accounting standards
• Differences: No significant differences were noted in the reporting period

Summary of Key Points

• The company reported a 10.14% increase in operating revenue compared to 2022
• Net profit declined by 28.02%, primarily due to changes in accounting policies and non-recurring items
• Dividend distribution of CNY6.00 per 10 shares was announced
• Corporate governance is well-structured with continuous supervision by Guosen Securities
• The cosmetics industry in China is expected to maintain high growth despite economic challenges
• The company is compliant with relevant disclosure requirements under the Shenzhen Stock Exchange guidelines
• Documents are available for inspection at the Board Secretary’s Office

Conclusion

Yunnan Botanee Bio-Technology Group Co., Ltd. demonstrated a mixed financial performance in 2023, with revenue growth but a notable decline in net profit. The company is actively engaged in the cosmetics and daily chemical manufacturing sectors, and its operations are aligned with regulatory and disclosure requirements. The report provides comprehensive details on governance, financial indicators, and strategic direction, with all documents accessible for review.